Dehydroabiethylamine
Dehydroabiethylamine (NSC-2955) is a small molecule with research applications in oncology and metabolism. It functions as a hepatic CYP2B inducer and inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport, demonstrating anti-tumor activity in experimental models.
Product Specifications
CAS Number
1446-61-3
Product Name Alternative
Inhibitor, Leelamine, Leelamine free base, NSC 2955, inhibit, NSC2955, NSC-2955, Dehydroabiethylamine, Dehydroabietylamine, CYP2B, Cannabinoid Receptor, PDHK, PDH kinase, PDK, Pyruvate dehydrogenase kinase
Field of Research
Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
97.24% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.01 mM) ; DMSO:25 mg/mL (87.57 mM)
Smiles
[H][C@@]12CCc3cc (ccc3[C@@]1 (C) CCC[C@@]2 (C) CN) C (C) C
Molecular Formula
C20H31N
Molecular Weight
285.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QP6451-ec-500ug 500ug
Recombinant Human Obg-like ATPase 1 Protein, His-SUMO, E.coli-500ug
Sign In for Pricing
View Details 
PT_39989-01 2 µg
B-Cell Leukemia/Lymphoma 2 Human Recombinant (-BH1)
Sign In for Pricing
View Details PT_39989-02 10 µg
B-Cell Leukemia/Lymphoma 2 Human Recombinant (-BH1)
Sign In for Pricing
View Details